Lyphochek Tumor Market Plus Control Level 1, 2 and 3 and Minipak
Multi-Analyte Controls, All Kinds (Assayed). 510(k) K082036, from Bio-Rad Laboratories (Irvine, CA). Product code JJY, class 1.
As of Nov 21, 2026, K082036 is an FDA 510(k) held by Bio-Rad Laboratories, substantially equivalent on Sep 8, 2008 after 53 days, with no recalls tied to it in FDA's recall database.
- Review time: 53 days
- Recalls: 0
- Cited as a predicate by: 1 device
Lyphochek Tumor Marker Plus Control is intended for use as an assayed quality control serum to monitor the precision of laboratory testing procedures for the analytes listed in the package insert. Domestic Analytes Listed - Adrenocorticotropic Hormone (ACTH) - Alpha Fetoprotein (AFP) • Aldosterone Beta-2-Microglobulin (B2M) • CA 15-3 • CA 19-9 • CA 27.29 • CA 125 • Calcitonin - Carcinoembryonic…
- Lyphochek Tumor Marker Control, Levels 1 and 2, 2ML, Model 580K011579 · Bio-Rad · Jun 26, 2001
- Fujirebio Diagnostics Tumor Marker Control Model 108-20K101809 · Fujirebio Diagnostics,Inc. · Oct 5, 2010
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 17, 2008
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1660
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files